Arunijyoti Bio Ventures Commissions New Jelly Pouch Production Line for Tata Consumer Products

1 min read     Updated on 10 Mar 2026, 06:46 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Arunijyoti Bio Ventures Limited has commissioned a new jelly pouch production line at its Jangaon, Telangana facility to manufacture ₹5/- jelly pouches for Tata Consumer Products Limited. Commercial production began on 10.03.2026 with the launch of two products: TGP Jelly Lychee and TGP Jelly Strawberry in 50ml pouches for the domestic ready-to-eat fruit jelly market. This strategic installation enhances production capacity and strengthens the business relationship with Tata Consumer Products Limited.

34694199

*this image is generated using AI for illustrative purposes only.

Arunijyoti Bio Ventures Limited has announced the successful installation and commissioning of a new jelly pouch production line at its manufacturing facility in Jangaon, Telangana. The company made this disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Production Line Details

The newly installed production line has been specifically set up to manufacture ₹5/- jelly pouch packs for supply to Tata Consumer Products Limited. This strategic installation is expected to significantly enhance the company's production capacity and further strengthen its business relationship with Tata Consumer Products Limited.

Parameter: Details
Facility Location: Jangaon, Telangana
Commercial Production Start: 10.03.2026
Client: Tata Consumer Products Limited
Product Price Point: ₹5/- per pouch

Product Launch Information

The commissioning has enabled the launch of two new products in the ready-to-eat fruit jelly and confectionery category:

Product Details: Specifications
Product 1: TGP Jelly Lychee 50ml pouch pack96 Rs5
Product 2: TGP Jelly strawberry 50ml pouch pack96 Rs5
Launch Date: 10.03.2026
Market Focus: Domestic Market
Category: Jelly Pouch for Ready-to-eat Fruit Jelly / Confectionery Product

Strategic Impact

The commissioning of this production line will enable the company to meet growing demand more effectively while improving operational efficiency. This development represents a significant step in expanding Arunijyoti Bio Ventures Limited's manufacturing capabilities in the confectionery segment.

The company operates from multiple locations including its registered office in Madhapur, Hyderabad, and manufacturing units in Jangaon, Telangana, and East Godavari, Andhra Pradesh. The new production line adds to the company's existing manufacturing infrastructure and strengthens its position in the food processing sector.

Historical Stock Returns for Arunjyothi Bio Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
-4.18%-5.26%-3.93%+4.27%-49.93%+6,208.33%
Arunjyothi Bio Ventures
View Company Insights
View All News
like17
dislike

Arunjoyoti Bio Ventures Reports Q3FY26 Profit of ₹4.67 Lakhs, Revenue Rises 21%

2 min read     Updated on 30 Jan 2026, 01:31 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Arunjoyoti Bio Ventures Limited announced Q3FY26 results showing significant improvement with net profit of ₹4.67 lakhs versus previous quarter's loss of ₹122.73 lakhs. Revenue from operations increased 21% sequentially to ₹646.82 lakhs, while nine-month performance showed net profit of ₹86.48 lakhs compared to ₹74.90 lakhs in the corresponding period last year.

31305717

*this image is generated using AI for illustrative purposes only.

Arunjoyoti Bio Ventures Limited has announced its unaudited financial results for the quarter ended December 31, 2025, reporting a significant turnaround with a net profit of ₹4.67 lakhs compared to a loss of ₹122.73 lakhs in the previous quarter. The company's board meeting held on February 3, 2026, approved these results along with the Limited Review Report.

Financial Performance Highlights

The company demonstrated strong operational improvement in Q3FY26. Revenue from operations increased to ₹646.82 lakhs from ₹533.65 lakhs in Q2FY26, representing a sequential growth of 21.21%. Total income for the quarter reached ₹648.01 lakhs compared to ₹534.86 lakhs in the previous quarter.

Financial Metrics: Q3FY26 Q2FY26 Q3FY25
Revenue from Operations: ₹646.82 lakhs ₹533.65 lakhs ₹615.38 lakhs
Total Income: ₹648.01 lakhs ₹534.86 lakhs ₹621.10 lakhs
Net Profit/(Loss): ₹4.67 lakhs (₹122.73 lakhs) (₹88.76 lakhs)
Earnings Per Share: ₹0.003 (₹0.07) (₹0.05)

Nine-Month Performance

For the nine months ended December 31, 2025, the company reported total income of ₹2,055.32 lakhs compared to ₹2,287.14 lakhs in the corresponding period of the previous year. Despite lower revenue, the company achieved a net profit of ₹86.48 lakhs for the nine-month period, showing improvement over the ₹74.90 lakhs profit recorded in the same period last year.

Nine-Month Performance: FY26 (9M) FY25 (9M)
Total Income: ₹2,055.32 lakhs ₹2,287.14 lakhs
Net Profit: ₹86.48 lakhs ₹74.90 lakhs
Earnings Per Share: ₹0.05 ₹0.04

Board Meeting Details

The board meeting was conducted at the company's registered office at Door No.1-98/1/JSIC/6F/604-B 6th Floor, Jain Sadhguru Capital Park, Beside Image Gardens, Madhapur, Shaikpet, Hyderabad. The meeting commenced at 10:30 AM and concluded at 02:20 PM.

Meeting Details: Information
Date: February 3, 2026
Duration: 10:30 AM to 02:20 PM
Venue: Registered Office, Hyderabad
Key Approval: Q3FY26 Unaudited Financial Results

Regulatory Compliance

The financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed by the Audit Committee before board approval. PKF Sridhar & Santhanam LLP, the company's statutory auditors, conducted a limited review of the unaudited financial results as required under Regulation 33 of SEBI (LODR) Regulations, 2015. The communication was signed by P.B.N. Murthy, Whole-Time Director (DIN: 01445523), ensuring compliance with regulatory requirements.

Historical Stock Returns for Arunjyothi Bio Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
-4.18%-5.26%-3.93%+4.27%-49.93%+6,208.33%
Arunjyothi Bio Ventures
View Company Insights
View All News
like16
dislike

More News on Arunjyothi Bio Ventures

1 Year Returns:-49.93%